N-benzenesulphonyl-DL-alanine | 5652-27-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-benzenesulphonyl-DL-alanine
• 英文别名: rac-N-(phenylsulfonyl)-alanine；N-benzenesulphonyl-alanine；N-benzenesulfonyl-alanine；N-benzenesulfonyl-DL-alanine；N-Benzolsulfonyl-DL-alanin；N-Benzolsulfonyl-alanin；N-(phenylsulfonyl)-alanine；2-Benzenesulfonamidopropanoic acid；2-(benzenesulfonamido)propanoic acid
• CAS: 5652-27-7
• 化学式: C₉H₁₁NO₄S
• mdl: MFCD00601236
• 分子量: 229.257
• InChiKey: KHLXTMZRKBVYST-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  91.8
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-benzenesulphonyl-DL-alanine 在 氯化亚砜 作用下， 以 苯 为溶剂， 反应 3.0h， 生成 2-Benzenesulfonylamino-propionyl chloride
  参考文献：
  名称：

  Awasthi, Pamita; Mahajan, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2008, vol. 47, # 8, p. 1291 - 1297

  摘要：

  DOI：
• 作为产物：
  描述：

  苯磺酰氯 、 alkaline earth salt of/the/ methylsulfuric acid 在 氢氧化钾 作用下， 生成 N-benzenesulphonyl-DL-alanine
  参考文献：
  名称：

  Hedin, Chemische Berichte, 1890, vol. 23, p. 3198

  摘要：

  DOI：

文献信息

• [EN] S-NITROSOMERCAPTO COMPOUNDS AND RELATED DERIVATIVES<br/>[FR] COMPOSÉS DE S-NITROSOMERCAPTO ET DÉRIVÉS APPARENTÉS
  申请人：GALLEON PHARMACEUTICALS INC

  公开号：WO2009151744A1

  公开（公告）日：2009-12-17

  The present invention is directed to mercapto-based and S- nitrosomercapto-based SNO compounds and their derivatives, and their use in treating a lack of normal breathing control, including the treatment of apnea and hypoventilation associated with sleep, obesity, certain medicines and other medical conditions.

  本发明涉及基于巯基和S-亚硝基巯基的SNO化合物及其衍生物，以及它们在治疗正常呼吸控制缺失方面的用途，包括治疗与睡眠、肥胖、某些药物和其他医疗状况相关的呼吸暂停和低通气。
• [EN] PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED 3-AMINOPIPERIDINE<br/>[FR] PROCÉDÉ DE PRÉPARATION D'UNE 3-AMINOPIPÉRIDINE ENRICHIE EN ÉNANTIOMÈRES
  申请人：REUTER CHEMISCHE APPBAU KG

  公开号：WO2014128139A1

  公开（公告）日：2014-08-28

  The present invention relates to a process for the preparation of enantiomerically enriched 3-aminopiperidine, and in particular of its R-enantiomer (R)-3-aminopiperidine. The invention also relates to an enantiomerically enriched intermediate of said process and to specific acid-addition salts of 3-aminopiperidine (hereinafter also APIP) that are useful for obtaining a single enantiomer of APIP, and to crystalline (R)-3-aminopiperidine-dihydrochloride-monohydrateand crystalline (S)-3-aminopiperidine-dihydrochloride-monohydrate.

  本发明涉及一种制备对映体富集的3-氨基哌啶的方法，特别是其R-对映体（R）-3-氨基哌啶。该发明还涉及该过程的对映体富集中间体，以及对3-氨基哌啶（以下简称APIP）的特定酸加盐，用于获得APIP的单一对映体，并且涉及结晶的（R）-3-氨基哌啶二盐酸盐一水合物和结晶的（S）-3-氨基哌啶二盐酸盐一水合物。
• Synthesis of SubstitutedSe-Phenyl Selenocarboxylates from Terminal Alkynes
  作者：Marcello Tiecco、Lorenzo Testaferri、Andrea Temperini、Luana Bagnoli、Francesca Marini、Claudio Santi、Raffaella Terlizzi

  DOI：10.1002/ejoc.200400177

  日期：2004.8

  Se-Phenyl selenocarboxylates have been conveniently prepared from (phenylseleno)acetylenes by treatment with p-toluenesulfonic acid monohydrate in dichloromethane. This easy conversion is compatible with a broad range of oxygen- and nitrogen-containing functional groups. The Se-phenyl selenocarboxylates were easily converted into the corresponding esters and amides. (© Wiley-VCH Verlag GmbH & Co. KGaA

  通过在二氯甲烷中用对甲苯磺酸一水合物处理，可以方便地从（苯基硒基）乙炔制备硒基羧酸硒苯酯。这种容易的转化与广泛的含氧和含氮官能团兼容。Se-苯基硒代羧酸盐很容易转化为相应的酯和酰胺。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004)
• Synthesis, characterization, and biological activity of some aza-uracil derivatives
  作者：Ahmed Ahmed El-Barbary、Yehia Ahmed Hafiz、Mohamed Shaker Abdel-Wahed

  DOI：10.1002/jhet.235

  日期：2011.5

  Thiation of 1 by LR gave the corresponding 3,5‐dithioxo derivative 2 and the trimer 3. Methylation of 1 afforded the S‐methyl derivative 4. Compound 1 was fused with 6‐bromo‐2‐phenyl‐benzo[1,3‐d]oxazin‐4‐one (5) and gave 6. Condensation of 1 with some acid derivatives 7a, 7b, 7c, 7d and/or 8a, 8b, 8c yielded thiadiazolo‐triazine derivatives 9a, 9b, 9c, 9d and 10a, 10b, 10c. Compounds 9a,9c and 10c

  LR对1的硫代反应得到3,5-二硫代衍生物2和三聚体3。甲基化1可获得S-甲基衍生物4。将化合物1与6-溴-2-苯基-苯并[1,3-d]恶唑嗪-4-酮（5 ）融合，得到6。1与某些酸衍生物7a，7b，7c，7d和/或8a，8b，8c缩合生成噻二唑-三嗪衍生物9a，9b，图9c，9d和10a，10b，10c。将化合物9a，9c和10c水解，得到11a，11b，11c。乙酰化14种生成的单乙酰基和二乙酰基衍生物15和16。14种苯甲酰化可提供单和二苯甲酰基衍生物17和18。14与一些芳香醛产生9a，9b，9c。反应14用苯基（异硫代和/或异硫代）氰酸酯得到脲衍生物20a，20b。的硫杂化14以P 4 s ^ 10布置21。测试了新合成的化合物作为抗微生物剂。J.杂环化​​学。（2011）
• PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT OR AGENT FOR PREVENTING/AMELIORATING ROUGH SKIN AND EXTERNAL COMPOSITION FOR SKIN
  申请人：Shiseido Company, Limited

  公开号：EP1884230A1

  公开（公告）日：2008-02-06

  The invention provides a parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent that has a function such as parakeratosis inhibition, pore shrinkage, or rough skin -inhibition/abatement, poses no safety problems such as sensory irritation, and is very safe, and to further provide an external composition for skin to which a compound having the above-mentioned function has been added. The parakeratosis inhibitor agent, pore-shrinking agent, or rough skin preventing/amaliorating agent comprises one, two, or more compounds selected from the group consisting of α-amino acid derivatives and salts thereof. The external composition for skin comprises the one, two, or more compounds selected from the group consisting of α-amino acid derivatives and salts thereof as the above-mentioned parakeratosis inhibitor, pore-shrinking agent, or rough skin preventing/amaliorating agent.

  该发明提供了一种具有角化不全抑制、收缩毛孔或防止/改善粗糙皮肤功能的抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂，不会引起感觉刺激等安全问题，非常安全，并进一步提供了一种外用皮肤组合物，其中添加了具有上述功能的化合物。角化不全抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂包括从α-氨基酸衍生物和其盐组成的群中选择的一种、两种或更多化合物。外用皮肤组合物包括从α-氨基酸衍生物和其盐组成的群中选择的一种、两种或更多化合物，作为上述角化不全抑制剂、收缩毛孔剂或防止/改善粗糙皮肤剂。